A new study warns that rooftop solar’s emissions benefits are declining in the United States as power grids become less ...

As clean energy grows, so do the limits of how it’s measured. A new Nature Climate Change study warns that rooftop solar’s ...

The support network that has emerged through the Mises Institute is really important. We feel like we’re all alone, but ...

By Yuen Yuen Ang Conflicts, trade wars, inequality, and democratic decay fill today’s headlines. Each crisis appears to be ...

In the traditional view, affordances exist as options users perceive and act upon within their environment. However, in the age of genAI, affordances have become relational folds, dynamic exchanges in ...

James Ohlen, of KOTOR and Mass Effect fame, sat down to talk with us about the ongoing Odyssey of the Dragonlords revamp ...

This study offers a valuable advance for neuroscience by extending a visualization tool that enables intuitive assessment of how dendritic and synaptic currents shape the output of neurons. The ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...